ArticleFrontiers in oncology2025

Clinical outcomes of avelumab and pembrolizumab in advanced urothelial cancer: an observational multicenter retro-prospective study on patients undergoing treatment in clinical practice (AVePEm study).

Francesca Zacchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.